This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Geneva. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Sema Gwendolyn Kaderli: Innovator in Hybrid Hydrogels
Introduction
Sema Gwendolyn Kaderli is a prominent inventor based in Bernex, Switzerland. She has made significant contributions to the field of medical applications through her innovative work on hybrid hydrogels. Her research focuses on the development of compositions that can enhance medical treatments.
Latest Patents
Sema holds a patent for her invention titled "Hybrid Hydrogels." This patent relates to compositions and pharmaceutical formulations that include hyaluronic acid, chitosan, and at least one ionic compound in hydrogel form. The invention outlines their use in medical applications, methods of making these compositions, and medical devices that incorporate them.
Career Highlights
Sema Gwendolyn Kaderli is affiliated with the University of Geneva, where she conducts her research and development. Her work has garnered attention for its potential to improve medical treatments and patient outcomes.
Collaborations
Sema collaborates with notable colleagues, including Olivier Jordan and Robert Gurny. Their combined expertise contributes to the advancement of research in the field of hybrid hydrogels.
Conclusion
Sema Gwendolyn Kaderli is a trailblazer in the development of hybrid hydrogels, with a focus on enhancing medical applications. Her innovative work and collaborations position her as a key figure in the field of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile